Free Newsletter

FierceVaccines is a weekly update on the vaccine industry, with a special focus on the innovations revolutionizing the development and production of vaccines. Join thousands of lab research professionals who get FierceVaccines via weekly email. Sign up today!

About | View Sample | Privacy

Hottest Products

Compare Top Solutions in:

Evaluate more than 400,000 products >>

Featured Jobs

Clinical Research Coordinator
Lovelace Respiratory Research Institute - Albuquerque, NM
Hematology Oncology Consultant, Hematology - Louisiana North Job
Celgene Corporation - Louisiana, LA, US
Patient Support Specialist Job
Celgene Corporation - Berkeley Heights, NJ, US
Partner
Lundbeckfond Ventures - Copenhagen, Denmark
Laboratory Facility Manager
International AIDS Vaccine Initiative - New York, NY

More Jobs >>

Events

New Paradigms to Fund & Move Biotech
January 11-12, 2012 — San Francisco, CA
Health Market Science Webinar: 3 Steps to New Physician Opportunities
Nov. 17
Life Science in the Cloud
Nov 16, 2011 — Cambridge, MA
Biomarker Applications for Improved Clinical Trial Outcomes
Nov. 15-16 — Boston

More Events >>

Related Tags >> Provenge Dendreon

Medicare News

Most Popular Medicare Story

Medicare's Provenge review comes into clearer focus

September 2, 2010 — 6:43am ET | By John Carroll

With billions in revenue at stake, every new twist and turn in the saga revolving around the rollout of Provenge gets put under the microscope. Any possibility of market restrictions, a fear raised Read more...

Medicare Press Releases

UnitedHealth Group Business Makes Major Breakthroughs in Helping People Assess, Address Hearing Loss
Lake Norman Oncology Among First Nationally to Successfully Attest to Meaningful Use of Electronic Medical Records
WNDM Secures Additional International Sales; $150 K in New Orders for 2011
AstraZeneca Provides More Than Half Million People with Free Medicine in 2010
Reportlinker Adds The Impact of US Healthcare Reform on Pharma: Analyzing the Effects

Latest Headlines

Medicare panel backs Provenge
November 18, 2010
Medicare's Provenge review comes into clearer focus
September 2, 2010

Paid Research Reports

Trends in mHealth and Telemedicine
The Global Aesthetic Dermatology Market Outlook
Future Directions in Regenerative Medicine
Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline

More Research Reports >>

THE FIERCEMARKETS NETWORK